Tumor Cells Develop Predictable Characteristics That Are Not Random, Say Moffitt Cancer Center Researchers
Moffitt Cancer Center researchers found that these assumptions may be incorrect. In a new article published in the journal Cancer Research, they report that certain subpopulations can be predicted and do not develop randomly as previously thought.
20-Jun-2016 2:05 PM EDT Add to Favorites
Moffitt Cancer Center Researchers Present Phase 1 Study Results of Selinexor Combination Therapy for Multiple Myeloma Patients
TAMPA, Fla. – Moffitt Cancer Center will present results from a phase 1 study of selinexor in combination with liposomal doxorubicin and dexamethasone in patients with relapsed and refractory multiple myeloma. The findings will be discussed...
6-Jun-2016 1:05 PM EDT Add to Favorites
Moffitt Cancer Center Finds Radiation Therapy with Pembrolizumab, Bevacizumab Safe for Recurrent High-Grade Glioma Patients
Moffitt Cancer Center will present preliminary results from a phase 1 study testing whether the addition of pembrolizumab to radiation therapy and bevacizumab is safe and can control tumor growth for these patients.
4-Jun-2016 9:05 AM EDT Add to Favorites
Moffitt Researchers Report Improved Progression-Free Survival and Responses Rates for Lutathera Over Octreotide
Moffitt Cancer Center will present results of the phase 3 NETTER-1 study, showing clinically meaningful and significant results for Lutathera (77Lu-DOTA0-Tyr3-Octreotate) in patients with metastatic midgut neuroendocrine tumors (NETs). The data will...
3-Jun-2016 10:05 AM EDT Add to Favorites
A new Moffitt Cancer Center study being presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago and published in The Lancet Oncology shows that utilizing the immunotherapeutic agents nivolumab and ipilimumab could...
2-Jun-2016 8:05 AM EDT Add to Favorites
Counseling Guidelines Necessary for Pediatric Patients Receiving Fertility, Sexual Function Treatment
The drugs and therapies used to treat medical conditions often come with side effects. Doctors, pharmacists and other health care professionals strive to be sure we are made aware. But when the patient is under age, and the effects include...
19-May-2016 10:05 AM EDT Add to Favorites
Genetic Biomarker May Predict Nerve Pain Side Effects Associated with Prostate Cancer Treatment, Moffitt Researchers Say
Taxanes are a group of drugs commonly used to treat cancers of the breast, lung, ovary, or prostate, but its use can be limited by significant side effects. Researchers from Moffitt Cancer Center report prostate cancer patients who have a variation...
13-May-2016 1:05 PM EDT Add to Favorites
Moffitt Cancer Center Researchers Discover Liver Metastases have Different Radiation Sensitivities Based on Primary Tumor Histology
TAMPA, Fla. – Radiation is a commonly used therapeutic option to treat liver metastases, with the majority of tumors maintained under control after one year. However, some patients do not respond as well to radiation treatment, and the factors...
12-Apr-2016 4:05 PM EDT Add to Favorites